Laboratory Corporation of America Holdings
NYSE:LH

Watchlist Manager
Laboratory Corporation of America Holdings Logo
Laboratory Corporation of America Holdings
NYSE:LH
Watchlist
Price: 231.06 USD 0.68% Market Closed
Market Cap: 19.3B USD
Have any thoughts about
Laboratory Corporation of America Holdings?
Write Note

Laboratory Corporation of America Holdings
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Laboratory Corporation of America Holdings
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Laboratory Corporation of America Holdings
NYSE:LH
Net Income (Common)
$435.5m
CAGR 3-Years
-46%
CAGR 5-Years
-10%
CAGR 10-Years
-2%
DaVita Inc
NYSE:DVA
Net Income (Common)
$827.7m
CAGR 3-Years
-5%
CAGR 5-Years
15%
CAGR 10-Years
1%
Quest Diagnostics Inc
NYSE:DGX
Net Income (Common)
$838m
CAGR 3-Years
-27%
CAGR 5-Years
3%
CAGR 10-Years
5%
CVS Health Corp
NYSE:CVS
Net Income (Common)
$5B
CAGR 3-Years
-13%
CAGR 5-Years
2%
CAGR 10-Years
1%
Cigna Corp
NYSE:CI
Net Income (Common)
$3B
CAGR 3-Years
-29%
CAGR 5-Years
-7%
CAGR 10-Years
4%
R1 RCM Inc
NASDAQ:RCM
Net Income (Common)
-$61.2m
CAGR 3-Years
50%
CAGR 5-Years
-21%
CAGR 10-Years
-1%
No Stocks Found

Laboratory Corporation of America Holdings
Glance View

Market Cap
19.3B USD
Industry
Health Care
Economic Moat
None

Laboratory Corporation of America Holdings, commonly known as LabCorp, stands as a formidable player in the world of healthcare diagnostics. Emerging from a confluence of scientific innovation and business acumen, LabCorp has carved a niche within the intricate fabric of healthcare services. Since its inception, the company has excelled in offering a comprehensive suite of laboratory-based tests and services, empowering physicians and healthcare providers with critical insights needed for effective patient diagnosis and management. With its headquarters in Burlington, North Carolina, LabCorp operates a vast network of laboratories and patient service centers across the nation, providing services that range from routine blood work to sophisticated genomic testing. The essence of LabCorp’s business model lies in seamless integration across the healthcare continuum, driving both operational efficiency and profitability. Fundamentally, the company generates revenue by performing diagnostic tests on patient specimens, serving hospitals, managed care organizations, physician offices, and governmental agencies. As healthcare systems evolve towards precision medicine, LabCorp has harnessed emerging technologies and innovations like genomic testing to enhance its service offerings. This expansion not only aligns with changing healthcare paradigms but also fortifies its market leadership. By continually investing in research and development, LabCorp keeps its services at the cutting edge, ensuring steady growth and resilience in an ever-changing healthcare landscape.

LH Intrinsic Value
254.71 USD
Undervaluation 9%
Intrinsic Value
Price

See Also

What is Laboratory Corporation of America Holdings's Net Income (Common)?
Net Income (Common)
435.5m USD

Based on the financial report for Sep 30, 2024, Laboratory Corporation of America Holdings's Net Income (Common) amounts to 435.5m USD.

What is Laboratory Corporation of America Holdings's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-2%

Over the last year, the Net Income (Common) growth was -34%. The average annual Net Income (Common) growth rates for Laboratory Corporation of America Holdings have been -46% over the past three years , -10% over the past five years , and -2% over the past ten years .

Back to Top